ОСОБЕННОСТИ ИНТЕРАКТОМА МЕЖГЕННЫХ ВЗАИМООТНОШЕНИЙ ПРИ РАКЕ СЛИЗИСТОЙ ОБОЛОЧКИ ПОЛОСТИ РТА

1. Freshour S.L. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic acids research. 2021; 49 (D1): D1144 D1151.

2. Heath E.I., Grochow L.B. Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May; 59(5): 1043-55.

3. Kullich W.C., Mur E., Aglas F., Niksic F., Czerwenka C. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase 9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2006 Mar-Apr; 24(2): 155-60.

4. Lockwood C.J., Paidas M., Krikun G., Koopman L.A. et al. Inflammatory cytokine and thrombin regulation of interleukin 8 and intercellular adhesion molecule 1 expression in first trimester human decidua. J. Clin. Endocrinol. Metab. 2005 Aug; 90(8): 4710-5.

5. Szklarczyk D. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research. 2019; 47(D1): D607 D613.

6. Tomczak K., Czerwińska P., Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary oncology. 2015; 19(1A): A68.